JP Morgan Maintains Underweight on Agilon Health, Raises Price Target to $85
JP Morgan analyst Lisa Gill maintains Agilon Health (NYSE:AGL) with a Underweight and raises the price target from $31 to $85.
Read original at benzingaStocks · News reference
This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts upgraded various stocks, including BBY, BCE. See what other analysts think.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 11, 2026, 12:27 PM
- Checked
- Aug 11, 2026, 12:27 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Wells Fargo Maintains Overweight on Agilon Health, Raises Price Target to $146
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raises the price target from $141 to $146.
Read original at benzingaCitigroup Upgrades Agilon Health to Neutral, Raises Price Target to $115
Citigroup analyst Daniel Grosslight upgrades Agilon Health (NYSE:AGL) from Sell to Neutral and raises the price target from $105 to $115.
Read original at benzingaCompany News for Aug 27, 2026
Several major retailers reported stronger-than-expected second-quarter earnings results, driving significant stock price increases. Abercrombie & Fitch surged 35.7% after beating EPS estimates by 24%, while Kohl's, J.M. Smucker, and Williams-Sonoma also exceeded consensus expectations with modest gains.
Read original at zacks-investment-researchBarclays Maintains Equal-Weight on Abercrombie & Fitch, Raises Price Target to $155
Barclays analyst Adrienne Yih maintains Abercrombie & Fitch (NYSE:ANF) with a Equal-Weight and raises the price target from $114 to $155.
Read original at benzingaUBS Maintains Buy on Abercrombie & Fitch, Raises Price Target to $185
UBS analyst Mauricio Serna maintains Abercrombie & Fitch (NYSE:ANF) with a Buy and raises the price target from $153 to $185.
Read original at benzinga